Sexually transmitted infections

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/147

encourage image

There's no tags or description

Looks like no tags are added yet.

148 Terms

1
New cards

agents of STIs - bacteria (3)

Chlamydia trachomatis -> Chlamydia

Neisseria gonorrhoeae -> Gonorrhoea

Treponema pallidum -> Gonorrhoea

2
New cards

agents of STIs - viral (4)

  • Herpes simplex virus (HSV) -> genital ulcers

  • Human immunodeficiency virus (HIV) -> HIV and AIDS

  • Human papillomavirus (HPV) -> genital warts

  • Hepatitis B virus -> Hep B


3
New cards

agents of STIs - protozoa (1)

Trichomonas vaginalis -> vaginitis

4
New cards

agents of STIs - arthropods (2)

  • Phthirus pubis -> public lice

  • Sacroptes scabiei -> scabies


5
New cards

features of bacteria commonly causing STIs - list (7)

  • Highly infectious

  • No animal reservoir

  • Don't survive well outside host

  • Damage predominantly caused by immune response

  • Effectively treated by antibiotics -> patients and contacts

  • Prevented by condoms

  • Can be asymptomatic


6
New cards

strain - def

population of organisms that descend from single organism or pure culture

7
New cards

serovar (serotype) - def

variant strain of microbe that has distinct antigenic properties

8
New cards

genotype - def

specific set of alleles or genes carried in genome of an organism

9
New cards

infections caused by chlamydia - list (3)

genital infections

ocular infections

respiratory infections

10
New cards

infections and conditions caused by chlamydia trachomatis serovars D-K (4)

  • Conjunctivitis

  • Uro-genital tract infections

  • Reactive arthritis

  • Pneumonitis


11
New cards

chlamydia as an STI - features (4)

Most common bacterial STI globally

Typical symptom = discharge -> urethritis and cervicitis

Most infections = asymptomatic -> still infectious

Persistent infections common

12
New cards

chlamydia trachomatis - common sites of infection (5)

  • Cervix

  • Urethra

  • Pharynx

  • Rectum

  • Eye -> where columnar epithelial cells present


13
New cards

chlamydia trachomatis - infection summary (3)

Can ascend upper genital tract to cause infection, damage and infertility

Eg. endometritis, salpingitis, pelvic inflammatory disease, epididymitis, proctitis

Infection in newborn contraction during birth process -> conjunctivitis

14
New cards

chlamydia trachomatis - morphology (4)

Gram negative -> outer membrane LPS is truncated and not very endotoxic

Abnormal peptidoglycan

Small and non-motile

Obligate intracellular bacteria -> need host cell mitochondria for energy

15
New cards

chlamydia trachomatis - lifecycle stages (2)

Unique replication cycle (2-3 days) with distinct developmental stages

EB = infectious extracellular particles

RB = intracellular and in replicative phase -> do not survive outside cells

16
New cards

chlamydia trachomatis - lifecycle steps (5)

  1. Elementary body (EB) binds columnar epithelial cells by adhesins to enter via receptor mediated endocytosis

  2. No fusion of EB-containing endosome with lysosome -> multiple endosomes fuse to form an inclusion

  3. EB transforms into metabolically active reticulate body (RB) -> replicates inside inclusions

    • Prolonged RB phase -> persistence

  4. RB converted back to EB

  5. Release of EB from epithelial cell


17
New cards

chlamydia trachomatis - tissue damage summary

Damage caused predominantly by host immune response -> chronic inflammation

18
New cards

chlamydia trachomatis - recurrence of infection

Infections can recur -> more damage = no lasting immunity

Long term sequelae = ascending inflammatory damage -> non-invasive infection

Eg. pelvic inflammatory disease, infertility, ectopic pregnancy

19
New cards

chlamydia trachomatis - tissue damage steps (4)

  1. Infected epithelial cells produce chemokines and other immune mediators → influx of immune cells inc. neutrophils

  2. Innate and adaptive immune activation and cell death

  3. Continued immune activation → chronic inflammation -> cell damage and scar tissue formation

  4. Activated CD4+ and CD8+ T cells and macrophages produce IFN-gamma → prolonged RB phase


20
New cards

chlamydia diagnosis - methods list and summary (2)

  1. specimens → (self-administered) cervical or urethral swabs or first-pass urine

  2. tests → PCR on first pass urine or discharge samples or antigen detect via EIA RAT on self-collected vaginal swabs


21
New cards

chlamydia diagnosis - reasoning for first pass urine

First-pass urine = more concentrated epithelial cells as opposed to mid-stream sample for UTIs

22
New cards

chlamydia - treatment (4)

Antimicrobials target RBs -> require good penetration of tissues and cells

Preferred treatment = single dose of long-acting macrolide or 1 week dose of tetracycline

  • Macrolide antibiotics and tetracyclines = good tissue/ cell penetration a

  • Long acting or multiple doses required because life cycle is asynchronous and 2-3 days


23
New cards

Neisseria gonorrhoea - morphology (5)

  • Gram negative diplococcus -> often intracellular

  • Extremely fastidious

  • Grows best in CO2 enriched atmosphere

  • Similar clinical presentations to chlamydia

  • Motile


24
New cards

Neisseria gonorrhoea - implications of being motile

Females: bacteria may ascend genital tract -> PID

May also cause disseminated disease but rare

25
New cards

Neisseria gonorrhoea - symptoms (4)

When symptomatic, presents as urethritis a few days after contact -> other sites may be asymptomatic

Females have more asymptomatic infection than males

Newborns may contract conjunctivitis

Symptoms of pus and pain generally more severe than in chlamydial infection

26
New cards

neisseria gonorrhoea - life cycle steps (4)

  1. Targets mucosal columnar epithelial cells -> attaches via adhesins

Eg. pili, outer membrane proteins, lipo-oligosaccharide (form of LPS)

  1. Typically replicates at cell surface and spreads in mucosal secretions → pili have twitching motility

  2. May invade some cells -> translocation to sub-epithelial tissues to cause inflammation and dissemination

  • Invasion to cause systemic disease rare but possible

  1. Antigenic variation in pili and gonococcal surface proteins allows avoidance of antibody responses and prolongs infections


27
New cards

neisseria gonorrhoea - method to cause tissue damage and evade immune response (4)

Inflammatory response stimulated by LPS and peptidoglycan -> interaction with PRR and TLR

Can avoid killing by neutrophils and complement → invasive strains have altered LPS which lack certain outer membrane proteins

Production of IgA protease -> cleaves IgA so it can't opsonize bacteria and mark for phagocytosis

TNR production -> loss of ciliated epithelial cells

28
New cards

neisseria gonorrhoea - immunity

Re-infections common so no immunity from prior infection

29
New cards

neisseria gonorrhoea - importance of diagnosis and treatment

Early diagnosis and treatment needed to reduce possible sequalae of PID and infertility

30
New cards

neisseria gonorrhoea diagnosis - methods list summarised (3)

  1. Specimens:

  • collect discharge/ swab from urethra, cervix or other and gram stain and culture

  • PCR -> collect urine, self-administered vaginal swab

  • antigen detection via EIA RAT on self-collected vaginal swabs now available

  1. microscopy → gram stain shows intracellular and extracellular Gram-negative diplococci and polymorphonuclear neutrophils

  2. culture on GC biplate → has lysed blood and other components to control growth of normal microbiota, non-antibiotic side used as control and to identify antib


31
New cards

neisseria gonorrhoea - implications if not treated properly

Rapid antibiotic resistance and persistence if treatment incorrect -> efficient acquisition of genetic material from other sources

Horizontal gene transfer and naturally competent

32
New cards

neisseria gonorrhoea - treatment process (3)

Use antibiotic guidelines for current recommendations for empirical treatment

Culture = essential to determine antibiotic susceptibility

Currently: injectable beta-lactamase resistant cephalosporin and azithromycin → high rate of co-infection with chlamydia so beneficial to treat all patients with gonorrhoea with azithromycin as well

33
New cards

treponema pallidum - morphology (5)

  • Slender, spiral rod

  • Need special techniques to visualise -> eg. dark field microscopy

  • Motile -> periplasmic contractile flagella for corkscrew like movement

  • Very labile -> easily inactivated

  • Difficult to culture -> requires mammalian cell culture


34
New cards

treponema pallidum - infection summary (3)

Infection may be asymptomatic or symptomatic

Infection = invasive and spreads to region beyond initial infection

Can spread via placenta to foetus -> congenital infection

35
New cards

treponema pallidum - stages of infection and transmission list (4)

  1. Infection  -> ~3 week incubation period

  2. Primary syphilis

  3. Secondary syphilis

  4. Tertiary syphilis

    • Less common since testing/ treatment available

    • Targets eyes, ears, heart, brain -> eg. neurosyphilis

    • Patients may present with gummas -> non malignant tumours that degrade bone


36
New cards

treponema pallidum - primary syphilis symptoms (2)

Chancre (ulcer on point of infection site) or asymptomatic -> lesions very infections

Asymptomatic/ latent for 2-24 weeks

37
New cards

treponema pallidum - secondary syphilis symptoms (4)

  • Rash typically on hands and feet → lesions are infectious

  • Warty genital lesions

  • Lymphadenopathy

  • Asymptomatic/ latent for 3-30 years


38
New cards

treponema pallidum - tertiary syphilis symptoms (3)

  • Less common since testing/ treatment available

  • Targets eyes, ears, heart, brain -> eg. neurosyphilis

  • Patients may present with gummas -> non malignant tumours that degrade bone


39
New cards

treponema pallidum diagnosis - methods list (2)

  1. Swab from primary or mucosal secondary lesion → dark-ground microscopy or PCR from exudate

  1. Blood specimen → serological test for specific antibodies to treponemal antigens or for cross reactive antibodies to cardiolipin


40
New cards

treponema pallidum diagnosis - downside of serological testing for specific antibodies to treponemal antigens

Usually remain positive for life -> can only tell you if you have active syphilis or previously infected

41
New cards

treponema pallidum diagnosis - benefit of serological testing for cross reactive antibodies to cardiolipin

Correlates with disease activity -> identify if syphilis is active

Used to confirm active infection and to monitor response to treatment

42
New cards

treponema pallidum - treatment

Sensitive to penicillin -> use long acting penicillin

No reported resistance to penicillin -> some to azithromycin

43
New cards

treponema pallidum - importance of treatment (2)

prevents:

  • progression to tertiary syphilis that can develop from latent infection

  • congenital syphilis and its complications -> screen for antibodies during all pregnancies


44
New cards

herpesvirus - morphology (4)

  • Large and icosahedral

  • Enveloped -> lipid membrane is fragile

  • Double stranded linear DNA

  • Encode a large array of proteins -> enzymes, structural proteins, immune evasion


45
New cards

latency of herpesvirus

All Herpesviridae family members can remain latent in the host → eg. chickenpox, glandular fever, roseola infantum, Kaposi's sarcoma

Very common -> can almost regard HSV as normal flora

46
New cards

methods of herpes virus transmission - list (4)

  • Saliva

  • Vesicle fluid

  • Sexual contact

  • Birth canal

Infection usually requires direct contact -> enveloped viruses are labile

47
New cards

herpesvirus - serotypes (2)

HSV-1 and HSV-2

Can be distinguished by serological tests to detect antigens or PCR to detect genes

Both cause localised infections (eg. cold sores, genital herpes) and disseminated infections (eg. encephalitis, meningoencephalitis)

48
New cards

target cells of herpesvirus and method of entry

epithelial cells, fibroblasts and macrophages -> needs to infect skin

Gains entry via damaged skin or defective keratin layer

Mucous membranes have multiple target cells

49
New cards

herpesvirus - replication in epithelial cell steps (8)

  1. Glycoproteins on envelope (gpB and gpC) bind cell surface receptors inc. heparan and  sulphate -> not sufficient for entry

  2. Viral entry by fusion or endocytosis

    1. Binding triggers endocytosis of virus

    2. Binding triggers fusion of envelope with cell membrane

  3. Capsid release into cytoplasm

  4. Ds DNA enters nucleus and forms an episome

  5. Early mRNAs express proteins including DNA polymerase and thymidine kinase

  6. Viral linear dsDNA replicated

  7. Later mRNAs express structural proteins that package new genomes

  8. Virion particle maturation with envelope glycoprotein and release


50
New cards

herpesvirus - progression to disease

Production of large amounts of infectious virus leads to cell-cell spread and cell death -> loss of epithelial cells leads to formation of vesicles/ ulcers

Can spread from peripheral sites to CNS -> systemic damage

51
New cards

herpesvirus - disease symptoms

Infection may be asymptomatic

Transmission to non-immune contacts can occur during symptomatic or asymptomatic replication

52
New cards

HSV-1 - transmission summary

typically infects above the waist and spread by saliva

53
New cards

HSV-2 - transmission summary

typically spread by genital secretions

54
New cards

HSV-1 - signs and disease caused (6)

Cold sores

Gingivostomatitis

Herpetic whitlow

Keratoconjunctivitis

Encephalitis

Meningoencephalitis

55
New cards

HSV-1 - signs and disease caused

Predominantly causes genital herpes and neonatal herpes

56
New cards

herpesvirus - serotypes and cross-protection

Antibodies against HSV-1 partially protect against HSV-2

57
New cards

establishment of herpesvirus latency at primary infection - steps (3)

  1. HSV infection of epithelial cells results in rapid virus multiplication, apoptosis and spread

  2. Vesicles containing HSV form and infect sensory neurons

  3. Axonal transport to dorsal root ganglion results in latent infection

    • Virus genome maintained as circular DNA episome in ganglia nucleus

    • Few viral genes are expressed

    • Latency activated transcript RNAs (LATs) produced but no protein product


58
New cards

reactivation of herpesvirus at primary infection - steps (3)

  1. Certain stimuli and immunosuppression induces reactivation of HSV from episomal state

    • Some products of early genes seen in human trigeminal cell

  2. Virus is transported down sensory nerve

  3. Reinfection at mucocutaneous site results in fresh outbreak of vesicles or asymptomatic shedding


59
New cards

herpesvirus - maintenance of latency

latency stimulates immune system which tries to suppress reactivation

Large numbers of memory T cells, chemokines and cytokines = associated with HSV-1 infected ganglia

60
New cards

site of HSV latency for HSV-1 and HSV-2

HSV can spread from epithelial cells to dorsal root ganglia -> trigeminal ganglia for HSV-1 and sacral ganglia for HSV-2

61
New cards

innate defences induced by HSV (3)

PAMP-PRR interaction stimulate macrophages and dendritic cells to produce cytokines -> esp. IFN-alpha

Infected epithelial cells produce type 1 interferons (IFN-beta)

Type 1 interferons protect uninfected cells from virus infection and induce influx and activation of NK cells -> recognise and bind to HSV infected cells and lyse them

62
New cards

adaptive immune responses to HSV infection - cell-mediated (4)

CD4+ T cells important to provide help for activation of CD8+ T cells

Cytotoxic CD8+ T cells important in controlling HSV replication in skin/ mucosa and ganglia -> production of ICP47 by HSV infected cells inhibits MHC-I presentation and expression

HSV specific CD8+ T cells found clustered around ganglia but no damage is observed -> virus infection sustained but controlled

In genital lesions: migration of CD8+ T cells correlates with viral clearance

63
New cards

adaptive immune responses to HSV infection - humoral (3)

Maternal antibodies protect against neonatal infection during recurrences of maternal genital disease -> antibodies appear to have limited efficacy in protecting against all forms of HSV infection

Antibodies induced by experimental vaccines have not been associated with protection

Antibody deficient patients have few problems with recurrences compared to individuals with the antibody

64
New cards

immune defence against HSV infection in epithelial cells vs neurons

epithelial cells: replication stimulates complement activation, NK cell activation, T cell activation (although delayed by ICP47 production) and antibody production → lyse virus and or virus infected cells to eventuallt resolve infection

neurons: virus persists

65
New cards

cause of HSV persisting in neurons - list (3)

  • Limited production of viral proteins in episomal state

  • Low levels of neuron MHC class I expression

  • ICP47 inhibition of peptide transport to MHC-I


66
New cards

diagnosis of HSV infection - methods list (3)

  1. Grow virus -> slow and expensive

  2. Look for antigens or nucleic acids

  3. Look for antibodies


67
New cards

interpretation of HSV results - importance

Interpretation of results indicates whether a new or a recurrent episode of a latent infection

Important if genital infection occurs late in pregnancy -> baby may be at risk of contracting the virus during delivery

68
New cards

interpretation of HSV results - features (3)

Acute phase of infection: rapid increase in presence of HSV antigen and nucleic acid that are readily detected

  • Initial increase in IgM production, followed by production of IgG

  • Concentrations of IgM or IgG indicate whether it’s a new or recurrent episode

Change of transmission is higher during primary infection -> higher viral load

69
New cards

treating HSV infection - drug summary (3)

Acyclovir = guanosine (nucleoside) analogue used to treat HSV -> inhibits viral DNA replication in epithelial cells (not neurons)

Nucleoside = no phosphate groups → nucleoside analogues = lack 3' hydroxyl group required to form DNA polymer

Nucleotides = nucleosides that are phosphorylated at position 5 -> substrates for DNA polymerisation

70
New cards

treating HSV infection - benefit of acyclovir

Acyclovir only functions in herpesvirus infected host cells -> requires herpesvirus thymidine kinase

71
New cards

treating HSV infection - acyclovir mechanism (3)

  1. Acyclovir is mono-phosphorylated by herpes virus thymidine kinase -> host cell has no enzyme that can mono-phosphate acyclovir

  2. Further phosphorylated by host cell kinases

  3. Tri-phosphorylated acyclovir is in its active form -> can bind to DNA polymerase and terminate DNA polymerisation

    • No 3' hydroxyl for phosphodiester bond with next nucleotide -> premature termination


72
New cards

HSV control and management strategies - list (4)

No effective vaccines yet but will have to induce T and B cell responses

Antiviral therapies = effective in preventing/ reducing blisters -> cannot remove latent infection in neurons

Physical barriers can reduce spread → eg. condoms and gloves

Limited by virus being able to be shed by asymptomatic and symptomatic individuals

73
New cards

HSV and HIV correlation

HSV-2 genital disease = associated with increased transmission of HIV

74
New cards

global impact of HIV and AIDS (2)

Predominantly infects people in southern and sub-Saharan Africa

1/3 of deaths occur in Sub-Saharan Africa -> decreasing economic growth and increasing poverty

75
New cards

reasons behind difficulty in defeating HIV (5)

  • Adds its viral genome into host DNA causing permanent infection -> even when infected cells produce no new virions

  • Sustains highest mutation rate in biology

  • Transmitted by intimate human contact

  • Infects stigmatized populations of people

  • Infects crucial cells of immune system causes acquired immune deficiency syndrome (AIDS)


76
New cards

HIV modes of transmission - general list (3)

  • parenteral

  • sexual

  • mother to child


77
New cards

HIV modes of transmission - parenteral (3)

  • Blood transfusion

  • Needle-sharing during injection drug use

  • Percutaneous


78
New cards

HIV modes of transmission - sexual (5)

  • Receptive anal intercourse

  • Receptive pen-vaginal intercourse

  • Insertive and intercourse

  • Insertive peno-vaginal intercourse

  • Unprotected sex with HIV infected individuals on ART


79
New cards

HIV modes of transmission - mother to child (2)

  • Without prevention measures

  • With prevention measures including ARV prophylaxis


80
New cards

structure of HIV (6)

Enveloped virus -> needs moist transmission fluid to survive in environment and transmit successfully

Envelope glycoprotein = made of 2 subunit → GP 120 and GP 41

Matrix layer underneath envelope -> P17 protein

Cone shaped core -> composed of icosahedral capsid

Duplicate copies of full length viral genome coded by nuclear capsid protein

Series of enzymes coded off pol gene -> reverse transcriptase, integrase, protease

81
New cards

structural proteins of HIV - gap and pol genes

expressed as one polyprotein before autocleavage

82
New cards

structural proteins of HIV - summary (4)

very high rate of variability -> esp. for gag and envelope proteins

Envelope glycoproteins = expressed from spliced RNA -> only protein available to immune system

Gag -> structural proteins of capsid, matrix, core and nucleocapsid

Pol -> reverse transcriptase, integrase and protease

83
New cards

Phases of HIV infection - summary (3)

  1. primary infection → occurs within first weeks and months

  2. clinical latency

  3. opportunistic diseases


84
New cards

phases of HIV infection - primary infection features

occurs within first weeks and months

Rapid plummet in body and blood CD4+ T cells and rapid rise in plasma viremia

85
New cards

consequences of primary HIV infection (2)

HIV infects and kills >60% of gut associated lymphatic T cells in mucosa within days -> both active and resting memory T cells compromised

Loss of cytokines produced by immune cells leads to leakage of microbial produces across tight junctions (microbial translocation)

86
New cards

phases of HIV infection - clinical latency features (2)

Balance between levels of virus produced and immune response against virus until virus overcomes immune response

Initial immune response to HIV is vigorous and initially contains HIV replication -> establishes virological set point

87
New cards

phases of HIV infection - escape of HIV from immune system causes (4)

  • Extremely high rival mutation rate

  • Deletion of HIV-specific CD4 T cell clones

  • Failure of HIV specific Ab and CTL responses

  • Other mechanisms


88
New cards

phases of HIV infection - clinical latency monitoring

Equilibrium between viral replicative capacity and host anti-HIV defence can be measured using RT-PCR (reverse transcriptase PCR)

undetectable viral load considered to be <50 copies/ ml (>50 is considered to b AIDS)

89
New cards

effects of HIV on innate immune cells (3)

Neutrophils → reduced killing of bacteria

Macrophages → decrease phagocytosis and chemotaxis + decreased killing

Natural killer cells → decrease virus/ tumour cell killing

90
New cards

effects of HIV on adaptive immune cells (2)

B cells:

  • General increase in antibodies -> typically autoantibodies as no T cell activation

  • Poor response to vaccines

  • Reduced killing encapsulated bacteria

T cells:

  • Decreased T helper cells for B cell and APC activation

  • Decrease cytotoxic T cell to lyse other virally infected cells


91
New cards

HIV replication and immune system activation

Immune system activation can drive HIV replication

T cells = most productive at shedding new infectious virus particles

92
New cards

implications of HIV being active at all times even when patient feels well

If patient has been feeling sick for only a short time, they are likely to have been infected for years

93
New cards

HIV antivirals - targets listed (7)

Antiviral drugs predominantly target viral enzymes and structural protein functions at many steps of replication

  1. Attachment -> eg. CCR5 inhibitors

  2. Fusion -> block activity of envelope glycoproteins in drawing the two membranes together

  3. Uncoating -> eg. capsid inhibitors that prevent uncoating and assembly steps

  4. Reverse transcription -> eg. NRTIs and NNRTIs

  5. Integration of viral genome into host DNA -> eg. integrase inhibitor

  6. Assembly and budding -> eg. capsid inhibitors

  7. Maturation -> eg. protease inhibitors


94
New cards

HIV - HAART meaning

highly active anti-retroviral therapy

combination therapy with synergistic potency

95
New cards

purpose of HAART for HIV

Durable antiviral response

Minimises development of drug resistance -> combination of drugs reduces chance of developing drug resistance by overcoming high mutation rate

96
New cards

clinical benefit of HIV antiretroviral therapy to individual (6)

  • Decreased plasma HIV viral load

  • Decreased inflammation and immune activation

  • Decreased CD4+ reservoir size

  • Decreased mortality

  • Increased CD4+ cell count and immune health -> gut and lymph node integrity

  • Increased longevity


97
New cards

benefit of HIV antiretroviral therapy on transmission reduction (2)

  • Decreased HIV transmission to sexual partners

  • Decreased transmission to infecting partners and neonates


98
New cards

econological benefit of HIV antiretroviral therapy (2)

  • Decreased community HIV viral load

  • Decrease in HIV incidence in communities


99
New cards

HAART on HIV and AIDS

Prior to HAART -> infection with HIV associated with very low probability of survival

Late HAART era patients still have ~10 year shorter life expectancy than HIV-positive controls

Adhering to HAART regiment → shift to non-AIDS related causes of morbidity and mortality

Eg. heart disease, non-AIDS cancers, liver disease

100
New cards

UNAIDS - goal

end AIDS epidemic

90% diagnosed

90% on treatment

90% virally suppressed

UNAIDS targets has reduced deaths